Brian J. Pak
Corporate Officer/Principal bei Axela, Inc.
Profil
Brian J.
Pak is currently the Head of Assay Development at Axela, Inc. Prior to this, he worked as a Scientific Program Manager at Bio-Rad Laboratories, Inc. and as a Country Manager at Ciphergen Biosystems KK.
He holds a doctorate degree from Queen's University.
Aktive Positionen von Brian J. Pak
Unternehmen | Position | Beginn |
---|---|---|
Axela, Inc.
Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Brian J. Pak
Unternehmen | Position | Ende |
---|---|---|
Ciphergen Biosystems KK
Ciphergen Biosystems KK Electronic Equipment/InstrumentsElectronic Technology Ciphergen Biosystems KK markets and supplies protein chip systems and services for clinical, research and process proteomic applications. The company was founded in January, 1999 and is headquartered in Yokohama, Japan. | Corporate Officer/Principal | - |
BIO-RAD LABORATORIES, INC. | Corporate Officer/Principal | - |
Ausbildung von Brian J. Pak
Queen's University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIO-RAD LABORATORIES, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Axela, Inc.
Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada. | Health Technology |
Ciphergen Biosystems KK
Ciphergen Biosystems KK Electronic Equipment/InstrumentsElectronic Technology Ciphergen Biosystems KK markets and supplies protein chip systems and services for clinical, research and process proteomic applications. The company was founded in January, 1999 and is headquartered in Yokohama, Japan. | Electronic Technology |